Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
T.MAN Pharmaceutical PCLBKK:TMAN -0.88%21 Pretax Margin % is 22.20% as of Mar. 2026, which is 12% below its 10-year median of 25.18. GuruFocus rates BKK:TMAN with a GF Score™ of 21/100. The stock has 2 warning signs investors should review. Among 960 Drug Manufacturers companies, T.MAN Pharmaceutical PCL ranks better than 86.25% on this metric.
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
T.MAN Pharmaceutical PCL Pretax Margin % Related Terms
T.MAN Pharmaceutical PCL Pretax Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:TMAN vs ZTS, UTHR, VTRS: Pretax Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, T.MAN Pharmaceutical PCL's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
T.MAN Pharmaceutical PCL Pretax Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, T.MAN Pharmaceutical PCL's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where T.MAN Pharmaceutical PCL's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
T.MAN Pharmaceutical PCL (BKK:TMAN) has a Pretax Margin % of 22.20% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on T.MAN Pharmaceutical PCL and its competitors. This is 12% below median its historical median of 25.18. Over the past decade, T.MAN Pharmaceutical PCL's Pretax Margin % has ranged from 23.91 to 29.32. According to the industry distribution chart, T.MAN Pharmaceutical PCL ranks #132 out of 960 companies in the Drug Manufacturers industry, placing it in the top 13.7%.
Is T.MAN Pharmaceutical PCL's Pretax Margin % too high?
T.MAN Pharmaceutical PCL's current Pretax Margin % of 22.20% is 12% below median its 10-year median of 25.18. Over the past 10 years, this metric has ranged from a low of 23.91 to a high of 29.32. The Drug Manufacturers industry median Pretax Margin % is 7.28. T.MAN Pharmaceutical PCL's value of 22.20% is 204.9% above this industry median. Based on the distribution chart, T.MAN Pharmaceutical PCL ranks #132 out of 960 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, T.MAN Pharmaceutical PCL has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does T.MAN Pharmaceutical PCL's Pretax Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, T.MAN Pharmaceutical PCL ranks #132 out of 960 companies for Pretax Margin %. This places T.MAN Pharmaceutical PCL in the top 14% of its industry — outperforming the majority of peers. The industry median Pretax Margin % is 7.28. T.MAN Pharmaceutical PCL's value of 22.20% is 204.9% above this benchmark. Historically, T.MAN Pharmaceutical PCL's own Pretax Margin % has ranged from 23.91 to 29.32 over the past decade. While the company's 10-year median is 25.18 vs. the industry median of 7.28, T.MAN Pharmaceutical PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.28, based on 960 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. T.MAN Pharmaceutical PCL's current Pretax Margin % of 22.20% is 204.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on T.MAN Pharmaceutical PCL and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. T.MAN Pharmaceutical PCL's current Pretax Margin % is 22.20%, which is 12% below median its own 10-year median of 25.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is T.MAN Pharmaceutical PCL stock overvalued right now?
T.MAN Pharmaceutical PCL (BKK:TMAN) has a current Pretax Margin % of 22.20%. The current Pretax Margin % is 22.20%, which is 12% below median its 10-year median of 25.18 and 204.9% above the Drug Manufacturers industry median of 7.28. T.MAN Pharmaceutical PCL's overall GF Score™ is 21/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For T.MAN Pharmaceutical PCL (BKK:TMAN), the current Pretax Margin % is 22.20% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
T.MAN Pharmaceutical PCL is engaged in purchasing, importing, manufacturing, and distributing original equipment and in manufacturing, distributing, and exporting modern medicines, traditional medicines, dietary supplements, and healthcare products for the healthcare industry. It offers products through brands such as T.Nutrition, T.Derma, Mommy&Me, TMT, Heaven Herb, and T.Pharmaceutical. The company's reportable segments are: Segment for manufactured products under own brand, which derives key revenue, Segment for manufactured products under third parties' brand, and Segment for trading products.
21GF Score
Get the complete analysis for BKK:TMAN
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:TMAN has been successfully added to your 
